BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 23265146)

  • 1. Epidemiological study on the incidence of gastroesophageal reflux disease symptoms in patients in acute treatment with NSAIDs.
    Martín-de-Argila C; Martínez-Jiménez P
    Expert Rev Gastroenterol Hepatol; 2013 Jan; 7(1):27-33. PubMed ID: 23265146
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Results of the ALEGRIA study in Luxembourg. An epidemiological, observational study to describe symptom impact and control in patients with GERD and an evaluation of the GERD Impact Scale.
    Fritz R; Goodman N; Duquenne V; Taeter C
    Bull Soc Sci Med Grand Duche Luxemb; 2009; (2):141-52. PubMed ID: 19999624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Review: treatment of gastroesophageal reflux disease in the elderly.
    Poh CH; Navarro-Rodriguez T; Fass R
    Am J Med; 2010 Jun; 123(6):496-501. PubMed ID: 20569750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonsteroidal anti-inflammatory drug use as a risk factor for gastro-oesophageal reflux disease: an observational study.
    Ruszniewski P; Soufflet C; Barthélémy P
    Aliment Pharmacol Ther; 2008 Nov; 28(9):1134-9. PubMed ID: 18671778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment patterns in paediatric patients with a new diagnosis of gastroesophageal reflux disease.
    Ruigómez A; Hungin AP; Lundborg P; Johansson S; Wallander MA; García Rodríguez LA
    Eur J Gastroenterol Hepatol; 2011 Mar; 23(3):232-7. PubMed ID: 21258240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determinants of gastroesophageal reflux disease in adults with a history of childhood gastroesophageal reflux disease.
    El-Serag HB; Richardson P; Pilgrim P; Gilger MA
    Clin Gastroenterol Hepatol; 2007 Jun; 5(6):696-701. PubMed ID: 17544996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The pharmacological management of gastroesophageal reflux disease.
    Lowe RC; Wolfe MM
    Minerva Gastroenterol Dietol; 2004 Sep; 50(3):227-37. PubMed ID: 15729198
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heartburn, gastroesophageal reflux (GER), and gastroesophageal reflux disease (GERD).
    J Pract Nurs; 2008; 58(3):21-3. PubMed ID: 19180847
    [No Abstract]   [Full Text] [Related]  

  • 9. Understanding the GERD.
    Mitlyng BL; Ganz RA
    Minn Med; 2012 Apr; 95(4):42-5. PubMed ID: 22685899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of gastroesophageal reflux disease in Korea and associated health-care utilization: a national population-based study.
    Kim KM; Cho YK; Bae SJ; Kim DS; Shim KN; Kim JH; Jung SW; Kim N
    J Gastroenterol Hepatol; 2012 Apr; 27(4):741-5. PubMed ID: 21916988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical characteristics of gastroesophageal reflux disease with esophageal injury in korean: focusing on risk factors].
    Lee SJ; Jung MK; Kim SK; Jang BI; Lee SH; Kim KO; Kim ES; Cho KB; Park KS; Kim EY; Jung JT; Kwon JG; Lee JH; Yang CH; Park CK; Seo HE; Jeon SW
    Korean J Gastroenterol; 2011 May; 57(5):281-7. PubMed ID: 21623136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Therapy of gastroesophageal reflux disease (GERD)].
    Storr M
    Med Monatsschr Pharm; 2011 Dec; 34(12):446-54; quiz 455-6. PubMed ID: 22233024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is gastroesophageal reflux disease really a life-long disease: do babies who regurgitate grow up to be adults with GERD complications?
    Gold BD
    Am J Gastroenterol; 2006 Mar; 101(3):641-4. PubMed ID: 16542297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heartburn in primary care: problems below the surface.
    Holtmann G; Maldonado-Lopez E; Haag S
    J Gastroenterol; 2004 Nov; 39(11):1027-34. PubMed ID: 15580394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medical therapy for gastroesophageal reflux disease.
    Arora AS; Castell DO
    Mayo Clin Proc; 2001 Jan; 76(1):102-6. PubMed ID: 11155401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term management of gastroesophageal reflux disease and its complications.
    Richter JE
    Am J Gastroenterol; 1997 Apr; 92(4 Suppl):30S-34S; discussion 34S-35S. PubMed ID: 9127624
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [NSAID administration and esophageal pathology: interaction with gastroesophageal reflux disease (GERD) symptoms, risk factors and incidence of erosive esophagitis].
    Karateev AE; Uspenskiĭ IuP; Pakhomova IG; Nasonov EL
    Eksp Klin Gastroenterol; 2008; (3):11-6. PubMed ID: 19145877
    [No Abstract]   [Full Text] [Related]  

  • 18. [Gastroesophageal reflux disease in pregnancy].
    Nikolov A; Pevtichev S; Petrova D
    Akush Ginekol (Sofiia); 2013; 52(7):35-40. PubMed ID: 24505639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gastroesophageal reflux disease: pathophysiology and pharmacology overview.
    Dajani EZ
    J Assoc Acad Minor Phys; 2000; 11(1):7-11. PubMed ID: 10826019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors associated with gastroesophageal reflux disease relapse in primary care patients successfully treated with a proton pump inhibitor.
    López-Colombo A; Pacio-Quiterio MS; Jesús-Mejenes LY; Rodríguez-Aguilar JE; López-Guevara M; Montiel-Jarquín AJ; López-Alvarenga JC; Morales-Hernández ER; Ortiz-Juárez VR; Ávila-Jiménez L
    Rev Gastroenterol Mex; 2017; 82(2):106-114. PubMed ID: 28283313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.